医学
人口
癫痫
活检
疾病
小儿癫痫
儿科
组织谷氨酰胺转胺酶
内科学
胃肠病学
精神科
化学
酶
生物化学
环境卫生
作者
Shanna M. Swartwood,Jacob Wilkes,Joshua L. Bonkowsky,Cristina Trandafir
标识
DOI:10.1016/j.pediatrneurol.2021.03.003
摘要
Abstract Background Neurological manifestations are commonly reported in patients with celiac disease (CD). We aimed to characterize epilepsy features in a pediatric population with CD and the effect of a gluten-free diet (GFD) on seizure burden. Methods A retrospective chart review was performed on pediatric patients treated at the University of Utah and Primary Children's Hospital in Salt Lake City, Utah, with both epilepsy and CD and compared with a control group with epilepsy only. Results We identified 56 patients with epilepsy and biopsy-confirmed CD (n = 36, 64%) or elevated tissue transglutaminase antibodies (tTG-Ab) without biopsy-confirmed CD (n = 20, 36%). Age- and gender-matched controls were selected from patients with epilepsy only (n = 168). Patients with biopsy-proven CD or positive tTG-Ab had high percentage of drug-resistant epilepsy (DRE) compared with the control group (P Conclusions DRE was more prevalent in pediatric patients with biopsy-confirmed CD and positive tTG-Ab compared with the control group (which included childhood epilepsy syndromes), but comparable with the prevalence of DRE in the general population. Adherence to a GFD in combination with antiseizure medications appears to reduce seizure burden for those with CD and DRE.
科研通智能强力驱动
Strongly Powered by AbleSci AI